Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nephrogenic ascites: a poorly understood syndrome

T C Hammond1, M A Takiyyuddin

  • 1Navy Medical Center San Diego, CA.

Journal of the American Society of Nephrology : JASN
|November 1, 1994
PubMed
Summary

Nephrogenic ascites, a severe complication in end-stage renal disease (ESRD), presents as massive fluid buildup. Effective treatments like dialysis and transplantation offer hope, but prognosis remains poor without intervention.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A role for oxidative stress in suppressing serum immunoglobulin levels in lead-exposed Fisher 344 rats.

Archives of environmental contamination and toxicology·2000
Same author

Catecholamine storage vesicle protein expression in genetic hypertension.

Blood pressure·2000
Same author

High-performance liquid chromatography assay for N-acetylcysteine in biological samples following derivatization with N-(1-pyrenyl)maleimide.

Journal of chromatography. B, Biomedical applications·1996
Same author

Effect of angiotensin II on the renal response to amino acid in rats.

American journal of kidney diseases : the official journal of the National Kidney Foundation·1996
Same author

N-actylcysteine protects Chinese hamster ovary (CHO) cells from lead-induced oxidative stress.

Toxicology·1996
Same author

In vivo indices of oxidative stress in lead-exposed C57BL/6 mice are reduced by treatment with meso-2,3-dimercaptosuccinic acid or N-acetylcysteine.

Free radical biology & medicine·1996

Area of Science:

  • Nephrology
  • Internal Medicine

Background:

  • Nephrogenic ascites is a serious complication in patients with end-stage renal disease (ESRD).
  • The precise etiology and pathogenesis of nephrogenic ascites remain unclear.
  • Patients often exhibit hypertension, significant ascites, and cachexia, with a history of dialysis-related hypotension.

Observation:

  • Ascitic fluid in nephrogenic ascites is typically characterized as an exudate.
  • Clinical presentation includes massive ascites with minimal peripheral edema.
  • Associated symptoms may include hypertension and cachexia.

Findings:

  • Limited treatment options exist for nephrogenic ascites.
  • Continuous ambulatory peritoneal dialysis, peritoneovenous shunt placement, and renal transplantation show effectiveness in managing ascites.
  • Nephrogenic ascites carries a grave prognosis if left untreated.

Implications:

  • Early diagnosis and intervention are crucial for improving patient outcomes in ESRD.
  • Further research into the pathogenesis of nephrogenic ascites is warranted.
  • Understanding treatment efficacy is vital for managing this severe complication.

Related Experiment Videos